16 February 2024
ANGLE at the 6th ACTC meeting 2023
Visit us to experience the power of the Parsortix® PC1 system, our unique FDA cleared, and CE marked circulating tumor cell (CTC) enrichment technology, and...
Discover more
ANGLE at World Clinical Biomarkers & CDx Summit
Visit our booth to discuss how our innovative Parsortix® technology and downstream circulating tumor cell (CTC) assays could help with your clinical studies.
Discover more
Portrait Flex takes circulating tumor cell (CTC) analysis to the next level
Enhance your research with circulating tumor cell (CTC) analysis you can trust.
Discover more
Why CTCs and liquid biopsies could one day revolutionise NHS cancer care
The article is part of the Supporting the NHS Campaign 2023 and focuses on how new innovations could improve patient outcomes and support the NHS.
Discover more
4 December 2023
ANGLE launches new Portrait+ CTC Staining kit
This innovative new product provides advanced immunofluorescent staining of circulating tumor cells (CTCs) enriched from blood processed by Parsortix technology.
Discover more